DR. SELLS VEJ 16 ApS: Financial statements 2020
CVR: 26671132
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
DR. SELLS VEJ 16 ApS (CVR 26671132) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 70,090 and a net result of DKK 60,085 compared with DKK 59,954 the year before. Equity in the 2020 report amounted to DKK 915,196. The solvency ratio was 92.5%.
- Gross Profit
- DKK 70,090
- Profit/Loss
- DKK 60,085
- Equity
- DKK 915,196
- Total Assets
- DKK 989,466
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 70K | 60K | 915K | - |
| 2019 | - | 70K | 60K | 855K | - |
| 2018 | - | 71K | 58K | 795K | - |
| 2017 | - | 70K | 64K | 737K | - |
| 2016 | - | 68K | 60K | 1.3M | - |
Official annual report
How creditworthy is DR. SELLS VEJ 16 ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
DR. SELLS VEJ 16 ApS has published its annual report for 2019. Gross profit came to DKK 70,090, and the net result was DKK 59,954.
About DR. SELLS VEJ 16 ApS
DR. SELLS VEJ 16 ApS was a Danish company of the type Anpartsselskab based in Slagelse, founded in 2002. The company has been dissolved on 29 May 2024. The company was registered under the industry Anden finansiel formidling undtagen forsikring og pensionsforsikring, i.a.n.. In 2023, the company reported a gross profit of DKK 7,209 and a net result of DKK 25,965 compared with DKK -57,317 the year before. Equity in the 2023 report amounted to DKK 645,785.